Stay updated on Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page presents the ClinicalTrials.gov record for the pembrolizumab and gemcitabine sarcoma study, including its completed status, study results and measures, eligibility criteria, and protocol documents.
    Difference
    49%
    Check dated 2026-11-07T12:42:02.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-31T13:24:54.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A sitewide notice announces that NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during a transition. The study record itself still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-24T15:55:25.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page remains a 403 Forbidden error page. Its footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T15:50:08.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1. The page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-10T15:47:39.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with a minimal header and a Home link, indicating the requested study page is currently inaccessible.
    Difference
    0.5%
    Check dated 2026-09-26T16:48:04.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Gemcitabine in Leiomyosarcoma Clinical Trial page.